<DOC>
	<DOCNO>NCT00596687</DOCNO>
	<brief_summary>High blood glucose level surgical patient diabetes associate increased risk medical complication death . Improved glucose control insulin injection may improve clinical outcome prevent hospital complication . In patient undergone surgery , high blood glucose increase risk wound infection , kidney failure death . It know ; however , best insulin regimen patient undergo surgery . The use repeat injection regular insulin commonly use glucose control hospitalize patient diabetes . Recently , combination Lantus® Apidra® insulins show improve glucose control lower rate hypoglycemia ( low blood sugar ) . We hypothesize patient type 2 diabetes admit general surgery ward , treatment daily glargine ( Lantus ) plus supplemental glulisine insulin ( Apidra® ) produce good glycemic control lower rate hospital complication treatment regular insulin per slide scale ( SSRI ) . The present study aim determine insulin treatment best glucose control hospitalize patient diabetes . Glargine glulisine insulin approve use treatment patient diabetes FDA . Subjects include study type 2 diabetes admit Grady Memorial Hospital , Veterans Administration Medical Center , Emory University Hospital , Atlanta , Georgia . A total ~94 patient recruited institution . A post-hoc cost analysis hospitalization cost charge Rabbit surgery trial complete order determine difference hospitalization cost basal bolus insulin SSI regimen .</brief_summary>
	<brief_title>Basal Bolus Insulin Versus SSRI Type 2 Diabetes Undergoing General Surgery</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin glulisine</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>1 . Males female age 18 80 year admit general surgery service . 2 . Patients admit noncardiac elective emergency surgery trauma . 3 . A known history type 2 diabetes mellitus &gt; 3 month , receive either diet alone combination oral antidiabetic agent ( sulfonylurea , metformin , thiazolidinediones ) . 4 . Subjects must admission blood glucose &gt; 140 mg &lt; 400 mg/dL without laboratory evidence diabetic ketoacidosis ( serum bicarbonate &lt; 18 mEq/L positive serum urinary ketone ) . 1 . Subjects increase blood glucose concentration , without know history diabetes ( stress hyperglycemia ) . 2 . Subjects history diabetic ketoacidosis hyperosmolar hyperglycemic state , ketonuria . 3 . Acute critical illness CABG surgery expect require prolonged admission critical care unit ( ICU , CCU , SICU , Neuro ICU ) . 4 . Patients clinically relevant hepatic disease impair renal function , show serum creatinine ≥ 3.5 mg/dl . 5 . Mental condition render subject unable understand nature , scope , possible consequence study . 6 . Female subject pregnant breast feeding time enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>diabetes</keyword>
	<keyword>post-op complication</keyword>
	<keyword>inpatient hyperglycemia</keyword>
</DOC>